To cool or not to cool: Targeted temperature management to prevent ventricular tachycardia associated with Brugada syndrome

Abstract

Key Clinical Message A robust inflammatory and febrile response from acute viral illness such as with SARS‐CoV‐2 in patients with Brugada syndrome may lead to triggering of ventricular arrhythmias. The use of targeted temperature management (TTM) using cooling devices may mitigate the febrile triggering of ventricular arrhythmias in patients with Brugada syndrome. Abstract Brugada syndrome (BrS) is an autosomonal dominant genetic disorder, with a risk of ventricular tachycardia (VT). Triggers of VT in BrS include fevers. Here, we report a case of BrS secondary to SARSs‐CoV‐2 infection and the use of targeted temperature management (TTM) to decrease fever and prevent VT triggering.

Keywords

• Brugada syndrome
• targeted temperature management